Бронхиальная астма у лиц пожилого и старческого возраста

1. Parameswaran K, Hildreth AJ, Chadha D et al. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med 1998; 92: 573–7.
2. Stupka E, deShazo R. Asthma in seniors: P:art 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality. Am J Med 2009; 122: 6–11.
3. Ford RM. Aetiology of asthma: a review of 11551 cases (1958–1968). Med J Aust 1969; 1: 628–31.
4. Lee HY, Stretton TB. Asthma in the elderly. Br Med J 1972; 4: 93–5.
5. Trends in Asthma Mortality in the Elderly, Fact Sheet 92/1. London: Lung and Asthma Information Agency, Department of Public Health Sciences, St. George’s Hospital Medical School.
6. Mannino DM, Homa DM, Akinbami LJ et al. Surveillance for asthma – United States, 1980–1999. MMWR Surveill Summ 2002; 5: 1–23.
7. Enright PL, McClelland RL, Newman AB et al. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Research Group. Chest 1999; 116: 603–11.
8. Enright PL, Kronmal RA, Higgins MW et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study. Chest 1994; 106: 827–34.
9. Diette GB, Krishnan JA, Dominici F et al. Asthma in older patients: factors associated with hospitalization. Arch Intern Med 2002; 162: 1123–32.
10. Slavin RG, Haselkorn T, Lee JH et al. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol 2006; 96: 406–14.
11. Moorman JE, Mannino DM. Increasing U.S. asthma mortality rates: who is really dying? J Asthma 2001; 38: 65–71.
12. Bellia V, Pedone C, Catalano F et al. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest 2007; 132: 1175–82.
13. Barbee RA, Kaltenborn W, Lebowitz MD et al. Longitudinal changes in allergen skin test reactivity in a community population sample. J Allergy Clin Immunol 1987; 79: 16–24.
14. Huss K, Naumann PL, Mason PJ et al. Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol 2001; 86: 524–30.
15. Pollart SM, Chapman MD, Fioco GP. Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol 1989; 83:75–82.
16. Yung RL. Changes in immune function with age. Rheum Dis Clin North Am 2000; 26: 455–73.
17. Haynes BF, Sempowski GD, Wells AF, Hale LP. The human thymus during aging. Immunol Res 2000; 22: 253–61.
18. Vignola AM, Scichilone N, Bousquet J et al. Aging and asthma: pathophysiological mechanisms. Allergy 2003; 58: 165–75.
19. Thurlbeck WM. Morphology of the Aging Lung. New York: Raven Press 1991.
20. Slavin RG. The elderly asthmatic patients. Allergy Asthma Proc 2004; 25: 371–3.
21. Barua P, O’Mahony MS. Overcoming gaps in the management of asthma in patients: new insights. Drugs Aging 2005; 22: 1029–59.
22. Morgan R, Pendleton N, Clague JE et al. Older people’s perceptions about symptoms. Br J Gen Pract 1997; 47: 427–30.
23. Lehmann S, Vollse SE, Nygaard HA et al. Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly. Respir Med 2004; 98: 1071–9.
24. Bellia V, Scichilone N, Battaglia S. Asthma in the elderly. Eur Respir Mon 2009; 43: 56–76.
25. Enright PL, Barr RG. Diagnosis and management of asthma in older adults. www.uptodate.com.
26. Mathur S. Allergy and asthma in the elderly. Semin Respir Crit Care Med 2010; 31 (5): 587–95. doi: 1055/s – 0030 – 1265899.
27. Kraft M. Asthma and chronic obstructive pulmonary disease exhibit common origins in any country! Am J Respir Crit Care Med 2006; 174: 238–40.
28. Calverley PM, Anderson JA, Celli B et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775–89.
29. Enright PL, Kronmal RA, Smith VE et al. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. Cardiovascular Health Study. Chest 1995; 107: 28–35.
30. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010; 376: 803–13.
31. Navaratnam P, Jayawant SS, Pedersen CA et al. Asthma pharmacotherapy prescribing in the ambulatory population of the United States: evidence of nonadherence to national guidelines and implications for elderly people. J Am Geriatr Soc 2008; 56: 1312–7.
32. NAEPP. NIH Publication №.07–4051. National Institutes of Health: National Heart, Lung, and Blood Institute; Aug 28. 2007. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma.
33. Global Initiative for asthma Management and Prevention. 2009 (update). www.ginasthma.org.
34. Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration 2008; 75: 18–25.
35. Marcus P, Oppenheimer EA, Patel PA et al. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Ann Allergy Asthma Immunol 2006; 96: 736–43.
36. Dolovich MB, Ahrens RC, Hess DR et al. Device selection and outcomes of aerosol therapy: Evodence-based guidelines: American College of Chest Physician/American College of Asthma, Allergy, and Immunology. Chest 2005; 127: 335–71.
37. Schmier JK, Halpern MT, Jones ML. Effects of inhaled corticosteroids on mortality and hospitalization in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence. Drugs Aging 2005; 22: 717–29.
38. Hartert TV, Togias A, Mellen BG et al. Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J Amer Geriatr Soc 2000; 48: 651–7.
39. Walsh LJ, Wong CA, Oborne J et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001; 56: 279–84.
40. Hubbard R, Tattersfield A, Smith C et al. Use of inhaled corticosteroids and the risk of fracture. Chest 2006; 130: 1082–8.
41. Suissa S, Baltzan M, Kremer R et al. Inhaled and nasal corticosteroid use and risk of fracture. Am J Respir Crit Care Med 2004; 169: 83–8.
42. Nelson HS, Weiss ST, Bleecker ER et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129: 15–26.
43. Shannon M. Life-threatening events after theophylline overdose: a 10-year prospective analysis. Arch Intern Med 1999; 159: 989–94.
44. Korenblat PE, Kemp JP, Scherger JE et al. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol 2000; 84: 217–25.
45. Hobbes FB, Dammon BL. US Census Bureau. 65+ in the United States. Current Population Reports: Special Studies 2001; 23–190.
46. www.demoscope.ru.

А.И.Синопальников, В.Г.Алексеев, В.Н.Яковлев

ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава РФ, Москва